FDA Acknowledgement Letter to Charlene Peters

This document is an acknowledgement letter from the FDA's Division of Management and Budget (DMB) to Charlene Peters, confirming receipt of a submission. The letter, authored by CDER, is noted as containing restricted personally identifiable information in its original form, with a redacted version also available. The purpose of this notice is purely administrative, confirming that a submission has been received by the agency.

For regulated entities, this notice signifies that a submission has entered the FDA's processing system. As it is merely an acknowledgement, it does not indicate approval, disapproval, or any specific action required from the recipient or other parties. Compliance officers should note that this is a standard procedural communication and does not impose new obligations or require immediate action beyond what may have already been submitted.